baber/WOPTO huggingface dataset:
Patent DE-69010758-T2 (DE)
Inventor: MERSCH STEVE HENRY
IPC: A61M5/158
Filed: 1990-05-04
Granted: 1994-10-27
Abstract: A flashback vent plug (22) is provided for catheters (16) with air vents (28) drilled by a laser beam which allow venting of the hollow plug (22) upon venous entry, but which vents (28) are so small that blood cannot pass. As a result, no leakage ever takes place. As a further feature of the invention, is the addition of a component to the resin making up the vent plug body (24) which optimizes absorption of the laser beam wave length. The air vent design of this invention provides sufficient cross-section for achieving the required air flow, and therefore rapid flashback and venous entry indication, yet its cost of manufacture is considerably reduced when compared to plug designs that involve multi-step assembly.
Patent DE-69022319-T2 (DE)
Inventor: POPE JOHN ANTHONY
IPC: B41M5/52
Filed: 1990-07-16
Granted: 1996-03-07
Abstract: A thermal transfer receiver sheet with improved handling properties comprises a sheet-like dielectric substrate supporting a receiver coat of dye-receptive material on one side, characterised in that there are antistatic treatments provided on both sides of the dielectric substrate, such treatments being sufficient on each side to reduce the surface resistivity to less than 1x10<1><3>  OMEGA /square. The side of the substrate remote from the receiver layer suitably has an antistatic backcoat for reducing the surface resistivity on that side, and the use of a textured surface provided by particulate materials either in the antistatic backcoat or in a further backcoat overlying the antistatic backcoat, may further improve the handling properties.
Patent DE-69024867-T2 (DE)
Inventor: RIGA ALAN THEODORE
IPC: C09K23/14
Filed: 1990-04-05
Granted: 1996-11-14
Abstract: Emulsifiers are disclosed which comprise the reaction product of component (I) with component (II). Component (I) comprises the reaction product of certain carboxylic acids or anhydrides, or ester or amide derivatives thereof, with ammonia, at least one amine, at least one alkali and/or at least one alkaline-earth metal Component (II) comprises certain phosphorus-containing acids; or metal salts of said phosphorus-containing acids, the metals being selected from the group consisting of magnesium, calcium, strontium, chromium, manganese, iron, molybdenum, cobalt, nickel, copper, silver, zinc, cadmium, aluminum, tin, lead, and mixtures of two or more thereof. These emulsifiers are useful in water-in-oil explosive emulsions.
Patent DE-69028935-T2 (DE)
Inventor: ISHIZAKI JUN
IPC: C07K1/20
Filed: 1990-01-30
Granted: 1997-03-06
Abstract: A novel method for producing glucagon is provided. The method comprises the steps of, preparing a fusion protein shown by the following formula:  X-Glu-Glucagon      (I) wherein X is a leader sequence of 70-170 amino acids, Glu is a glutamic acid residue, and Glucagon represents the amino acid sequence of glucagon, and treating the fusion protein with an enzyme that specifically hydrolyzes the peptide bonds at the carboxyl termini of the glutamic acid residues, resulting in cleavage of the fusion protein.
Patent DE-69030386-T2 (DE)
Inventor: GELFAND DAVID
IPC: C12N15/09
Filed: 1990-12-21
Granted: 1997-10-09
Abstract: Methods are provided for the replication and amplification of RNA sequences by thermoactive DNA polymerases. Reverse transcription of RNA is catalyzed by, for example, 94 kDa Taq, 62 kDa Taq, nTth and recombinant Tth DNA polymerase. Reverse transcription is coupled to PCR amplification in a one enzyme procedure using a thermostable polymerase.
Patent DE-69031928-T2 (DE)
Inventor: AX ROY L
IPC: A61K38/00
Filed: 1990-07-30
Granted: 1998-05-20
Abstract: A method is disclosed relating to the isolation and purification of certain heparin-binding protein compositions in the seminal plasma of male mammals. The isolated proteins are useful in fertility studies and in enhancing the acrosomal reaction, capacitation and subsequent fertility of sperm cells.
Patent DE-69033587-T2 (DE)
Inventor: MARTIN F
IPC: A61K9/06
Filed: 1990-09-17
Granted: 2001-04-19
Abstract: The object of the invention is to provide a method and composition for treating blepharitis or blepharoconjunctivitis which comprises topical administration of a nitroimidazole compound, e.g. metronidazole in a suitable ophthalmic carrier directly to affected ocular tissues. The carrier can be based on an artificial tear solution, an ointment, a water soluble gel, a nonaqueous carrier or an eyelash shampoo.
Patent DE-69120158-T2 (DE)
Inventor: KRSTENANSKY JOHN L
IPC: A61P7/02
Filed: 1991-07-23
Granted: 1996-10-31
Abstract: This invention relates to peptide derivatives which are useful anticoagulant agents.
Patent DE-69120603-T2 (DE)
Inventor: LAIGLE JEAN-CLAUDE
IPC: A61P9/00
Filed: 1991-05-10
Granted: 1997-01-02
Abstract: The invention concerns an isochromane derivative having the general formula I <CHEM> in which R1 is one to four substituents independently selected from hydrogen, hydroxy, alkyl (1-4 C), alkoxy (1-4 C), halogen, or CF3, or as two adjacent substituents together a methylenedioxy group; R2 is one to four substituents independently selected from hydrogen, hydroxy, alkyl (1-4 C), alkoxy (1-4 C), halogen, or CF3, or as two adjacent substituents together a methylenedioxy group; R3 is one to four substituents independently selected from hydrogen, hydroxy, alkyl (1-4 C), alkoxy (1-4 C), halogen, or CF3, or as two adjacent substituents together a methylenedioxy group;  R4 is selected from hydrogen or alkyl (1-4 C); A is a bond or an alkylene or alkylidene group with 1-6 carbon atoms; B is an alkylene or alkylidene group with 1-6 carbon atoms when Y is a bond, or B is an alkylene group with 2-6 carbon atoms when Y is a group selected from O, S, or NR5;  X is CH or N; and  R5 is selected from hydrogen or alkyl (1-4 C);  or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of angina pectoris, cardiac dysrhytmias, cardiomyopathies, stroke, sudden death, and myocardial infarction.
Patent DE-69125197-T2 (DE)
Inventor: JONES FRANCIS
IPC: G02F1/1335
Filed: 1991-01-14
Granted: 1997-10-09
Abstract: A method of manufacturing a colour filter for a liquid crystal cell comprises forming a plurality of patterns, each of a respective dye intermediate material, on a carrier element. The patterns of dye intermediate materials are then brought into contact with a substrate layer, supported on a glass substrate, under the application of heat and pressure. The substrate layer, such as a polyacrylonitrile layer, contains free acid groups which interact with the dye intermediate materials to form the colours of the colour filter in the substrate layer. The method permits the actual formation of the colours on the substrate to be effected in a single alignment step, minimising wastage of the relatively expensive glass substrates. Furthermore, as the dyes providing the colours of the filter are chemically part of the substrate layer, they are very resistant to leaching by the liquid crystal materials. <IMAGE>
Patent DE-69132510-T2 (DE)
Inventor: AGRAWAL SUDHIR
IPC: C07H21/00
Filed: 1991-11-08
Granted: 2001-05-03
Abstract: Oligonucleotides containing multiple free amino groups attached directly to the phosphorus atoms of the phosphodiester linkages having the structure shown below.   <IMAGE>   wherein D=a ribonucleoside or deoxyribonucleotide; p=a 5' to 3'-phosphodiester or phosphoramidate linkage; n=1 to 20; a=1 to 20; b=1 to 20; c=1=20; z=0 to 20; t=1 to 100; and wherein for each repeating unit, "a" represents the same number or a different number than that number represented by "a" in every other repeating unit; and for each repeating unit "b" represents the same number or a different number than represented by "b" in every other repeating unit. Multiple reporter molecules can be incorporated into the oligonucleotide via the free amino groups allowing for increased probe sensitivity.
Patent DE-69205017-T2 (DE)
Inventor: NASU RIKUO
IPC: C07B61/00
Filed: 1992-01-23
Granted: 1996-05-30
Abstract: A process for producing 3,5-difluoroaniline, which comprises reacting a benzonitrile compound of the formula (I): <CHEM> wherein each of X1, X2 and X3 is hydrogen, chlorine, bromine or a cyano group, provided that at least one of X1 to X3 is a cyano group, with a mineral acid for hydrolysis and decarboxylation to obtain an aniline compound of the formula (II): <CHEM> wherein each of X4, X5 and X6 is hydrogen, chlorine or bromine, provided that at least one of X4 to X6 is hydrogen, and in the case of a compound of the formula (II) wherein X4, X5 and X6 are not simultaneously hydrogen, reacting such a compound with hydrogen in a presence of a catalyst for reduction to obtain 3,5-difluoroaniline.
Patent DE-69206142-T2 (DE)
Inventor: HEDSTROEM JONAS
IPC: H01L31/032
Filed: 1992-04-22
Granted: 1996-05-30
Abstract: PCT No. PCT/SE92/00262 Sec. 371 Date Oct. 22, 1993 Sec. 102(e) Date Oct. 22, 1993 PCT Filed Apr. 22, 1992 PCT Pub. No. WO92/20103 PCT Pub. Date Nov. 12, 1992.A method for manufacturing solar cells, more specifically thin-film solar cells, particularly thin-film solar cells on which CuInSe2 is deposited. A substrate is provided on which a multi-layer structure is formed by depositing thereon a layer defined by a compound including several basic substances, such as copper-indium-diselenide (CuInSe2), or a closely-related compound where copper (Cu) and indium (In) can be replaced totally or partially with Silver (Ag) and gallium (Ga), respectively, and where selenium (Se) can be replaced totally or partially with sulphur (S) and tellurium (Te), and where the concentration of the basic substances in the layer varies. The substrate is placed on the inside of a rotatable, tubular carrier device, after which the substrate is heated, and substance sources are provided for depositing the basic substances on the substrate. One or more of the basic substances is deposited on the substrate by passing respective basic substance sources axially into the tubular carrier device while simultaneously rotating the tubular carrier device.
Patent DE-69211916-T2 (DE)
Inventor: BROSSE GERARD
IPC: F02D35/00
Filed: 1992-04-17
Granted: 1997-02-27
Abstract: The detector includes a unipolar Hall effect pickup (3) for detecting the passage of a target (14) of soft magnetic material that is movable in displacement with the piston of the first cylinder and is intended to loop the field lines of a permanent magnet (4) to the sensitive zone of the pickup (3). The detector includes two magnets (4, 5) arranged to cancel the resting magnetic induction in the sensitive zone of the pickup (3).
Patent DE-69212135-T2 (DE)
Inventor: KUZMA PETER
IPC: B29K33/04
Filed: 1992-01-16
Granted: 1997-01-30
Abstract: A method is provided for the preparation of homogeneous copolymers having a predetermined equilibrium water content (EWC) value formed by the addition polymerization of a mixture of ethylenically unsaturated monomer A and ethylenically unsaturated monomer B, for example, 2-hydroxyethyl methacrylate and hydroxypropyl methacrylate. The method requires determining the EWC values of the hydrogel homopolymer of hydrophilic monomer A (homopolymer A) and the hydrogel homopolymer of hydrophilic monomer B (homopolymer B); determining the relationship of the EWC values of the homogeneous copolymers AB versus the chemical composition of said copolymers AB; selecting the targeted EWC value and determining the chemical composition of copolymer AB having the targeted EWC value; forming a polymerizable mixture of monomer A and monomer B in amounts sufficient to yield copolymer AB having the targeted EWC value; and effect the polymerization reaction to yield copolymer AB characterized by the targeted EWC value. A method is also provided for the preparation of a delivery device including a drug contained in the reservoir of the hydrogel of copolymer AB, said device being characterized by its capability of eluting or releasing the drug through the hydrogel membrane to a delivery environment at a predetermined rate. There is also disclosed a sterilized kit containing a trocar or hypodermic needle/syringe and the aforesaid drug delivery device having a cylindrical shape with a rounded or bullet-like extremity.
Patent DE-69214839-T2 (DE)
Inventor: VAN DER HERBERG JAN WYTZE
IPC: C02F3/12
Filed: 1992-07-02
Granted: 1997-02-27
Abstract: PCT No. PCT/NL92/00119 Sec. 371 Date Dec. 30, 1993 Sec. 102(e) Date Dec. 30, 1993 PCT Filed Jul. 2, 1992 PCT Pub. No. WO93/01137 PCT Pub. Date Jan. 21, 1993.The invention relates to a device for purifying waste water, comprising a reservoir (2), supply means (3) for the waste water flowing out into the reservoir, means for maintaining a pre-determined fluid level (11) in the upper part of the reservoir and draining means (12) for draining purified water from the reservoir. Said reservoir forms part of a cycle of microbe supporting elements (8) that have a lower density than 1, and comprising means (15) for removing microbe supporting elements from the reservoir operative above the pre-determined level, cleaning means (17) for removing sludge from the supporting elements, and re-introducing means (20) flowing out into the lower part of the reservoir for re-introducing the cleaned microbe supporting elements.
Patent DE-69216904-T2 (DE)
Inventor: EVANS ARNOLD KERRY
IPC: A61B5/308
Filed: 1992-04-24
Granted: 1997-08-14
Abstract: A system (10) is disclosed that includes a monitor (16) for use in performing 12-lead electrocardiographic (ECG) and body surface mapping (BSM) analyses on a patient (12) with a single ten-electrode cable set (14). The monitor receives nine leads of data from the electrode cable set and initially preprocesses it to simplify further analysis. Then the data is transformed to produce a spatial distribution relative to the patient's chest, representative of the data that would be collectible with a 192-electrode set. Feature extraction techniques are also described for use in evaluating transformed, as well as conventional, BSM data with respect to clinically evaluated populations. In that regard, features of interest are extracted from the data and statistically analyzed to detect select cardiac conditions. <IMAGE>
Patent DE-69229586-T2 (DE)
Inventor: ANDERSON MARC
IPC: B01J20/02
Filed: 1992-05-01
Granted: 2000-02-10
Abstract: A method of making metal oxide ceramic material is disclosed by which the porosity of the resulting material can be selectively controlled by manipulating the sol used to make the material. The method can be used to make a variety of metal oxide ceramic bodies, including membranes, but also pellets, plugs or other bodies. It has also been found that viscous sol materials can readily be shaped by extrusion into shapes typical of catalytic or adsorbent bodies used in industry, to facilitate the application of such materials for catalytic and adsorbent applications.
Patent DE-69229637-T2 (DE)
Inventor: AKASAKA KOZO
IPC: A61K31/445
Filed: 1992-09-30
Granted: 1999-12-09
Abstract: An oxazolidone derivative represented by general formula (I) and having a monoamine oxidase inhibitory activity, a pharmacologically acceptable salt thereof, and a drug containing the same as the active ingredient for preventing or treating diseases for which a monoamine oxidase inhibitory activity is efficacious. In formula (I) A and B represent each nitrogen, sulfur or oxygen provided that either A or B represents nitrogen; R<1> represents a group of formula (a) wherein n and m represent each an integer of 0, 1 to 4; and R<3> and R<4> represent each hydrogen, hydroxy, lower alkyl, etc.; a group of formula (b) wherein p and q represent each an integer of 0, 1 to 4; and X represents oxygen, sulfur, etc., a group of formula (c) wherein R<5> and R<6> represent each hydrogen, cyanoalkyl, etc., or alternatively R<5> and R<6> are bonded to each other to represent a ring together with the nitrogen atom to which they are bonded; and so forth; R<2> represents hydrogen or lower alkyl; and the bond ---- represents either a single or a double bond. <CHEM>
Patent DE-69231644-T2 (DE)
Inventor: MOCHIZUKI MANABU
IPC: C07H19/01
Filed: 1992-04-24
Granted: 2001-05-23
Abstract: PCT No. PCT/JP92/00545 Sec. 371 Date Apr. 1, 1994 Sec. 102(e) Date Apr. 1, 1994 PCT Filed Apr. 24, 1992 PCT Pub. No. WO92/19278 PCT Pub. Date Nov. 12, 1992.Macrolide compounds such as the FR-900506 and its related compounds are provided for the prevention or treatment of eye diseases, particularly, allergic conjunctivitis. Composition containing such compounds is also disclosed.
Patent DE-69232377-T2 (DE)
Inventor: THERASSE YVES
IPC: H04L12/56
Filed: 1992-11-30
Granted: 2002-08-14
Abstract: A resequencing device for a cell switching system node particularly includes: a time stamp generator (TSG), for allocating a time stamp to each cell, a buffer memory (BM), an address memory (FSAM) for storing the address of the first sub-cell of each cell, a link memory (LM), and a circuit (CU) for recovering the address of the buffer memory containing the first sub-cell of a cell. This circuit particularly includes: a content-addressable memory, for storing a cell identifier (TSTP-OA; TSTP-OM) when a cell is placed on hold, each identifier identifying a time interval in which the waiting time will expire, and at least one output where the cell has to be sent; and a memory of markers for each output, a marker being written as soon as a cell is placed on hold, in order to mark the time interval in the course of which the waiting time of this cell will expire; the markers being read from the oldest, and enabling only those corresponding to expired time scales, when the output in question shows that it is available; and each marker possibly being common to several cells. <IMAGE>
Patent DE-69303598-T2 (DE)
Inventor: CATALFAMO GIUSEPPE
IPC: B24B23/02
Filed: 1993-01-22
Granted: 1997-02-20
Abstract: PCT No. PCT/IT93/00004 Sec. 371 Date Jul. 8, 1994 Sec. 102(e) Date Jul. 8, 1994 PCT Filed Jan. 22, 1993 PCT Pub. No. WO93/14904 PCT Pub. Date Aug. 5, 1993.Smoothing mill for compressed ejectors (3,4) of several stages, incorporated, for suction of dust generated and for conveying it through a flexible tube (19) to a collecting area, use being made of the compressed air discharged from the motor (40) which sets the abrasive disk (9) in rotation.
Patent DE-69310097-T2 (DE)
Inventor: BRENOT CLAUDE
IPC: F22B1/28
Filed: 1993-10-26
Granted: 1997-11-20
Abstract: The steam generator comprises a metal body (11) defining a cavity (12) which constitutes a vaporisation chamber, a heating member (14) arranged in the body (11) in the vicinity of the cavity (12), a first connection (15) for the injection of liquid into the cavity (12), a second connection (16) for the removal of the steam formed in the cavity (12), and a lining consisting of a set of calibrated metal balls (13) which are in contact with one another and arranged in the entire section of the cavity (12) to increase the degree of vaporisation of the liquid introduced into the cavity (12). Application to instantaneous steam generators, in particular for iron or ironing press. <IMAGE>
Patent DE-69310504-T2 (DE)
Inventor: LINDBERG LENNART
IPC: H03H3/02
Filed: 1993-02-24
Granted: 1997-09-11
Abstract: A method and a manufacturing plant for producing resonators, comprising cleaning the piezoelectric discs (91) of the resonator elements to atomic purity immediately prior to applying electrodes thereto. The resonator elements (9) are transported into and out of an ultra-high vacuum chamber (3), constructed as an electrode coating station (3b), via high vacuum chambers (1, 4).
Patent DE-69310554-T2 (DE)
Inventor: LEE KYU H
IPC: B01D61/22
Filed: 1993-01-12
Granted: 1997-09-18
Abstract: An apparatus and method are disclosed for continuous, on-line monitoring of extracorporeal blood in a blood path. A shell (10) has a blood inlet port (14), a blood outlet port (16) and two compartments: a blood compartment (12) and a plasma compartment (18) separated by a semi-permeable membrane (20) that allows plasma to pass, but not red blood cells. Blood flows through the blood compartment (12) and transmembrane pressure is applied between the blood (12) and the plasma compartments (18) causing the plasma inside the plasma compartment (18) to be replaced by fresh plasma that is flowing through the blood compartment (12). Any color change of the plasma in the plasma compartment (18) can be detected. <IMAGE>
Patent DE-69320096-T2 (DE)
Inventor: GONELLA JACQUES DR
IPC: A61K9/70
Filed: 1993-05-07
Granted: 1998-12-10
Abstract: The adhesive plaster for the transdermal administration of estradiol or mixture estradiol/ progestin is composed of an impermeable carrier film and of an adhesive composition. The latter represents a matrix or reservoir layer and is composed of a solvent-based polyacrylate or polyisobutylene adhesive which contains a saturated or unsaturated fatty acid with 6 to 18 C atoms as permeability enhancer, estradiol or mixture estradiol/progestin as active substance and optionally propylene glycol as solvent. The adhesive plaster is used for the systemic administration of hormones in hormone replacement therapy for a time of at least 3 days.
Patent DE-69323320-T2 (DE)
Inventor: RIMSA STEPHEN
IPC: C08L1/00
Filed: 1993-10-06
Granted: 1999-09-02
Abstract: According to the present invention there is provided a composition as obtained from a melt comprising esterified starch, preferably having a degree of substitution of at least about 1.5, and preferably an amylose content of at least about 50% by weight with respect to that of the starch, and a linear polyester. The invention further provides the composition in the form of a melt or when shaped into articles.
Patent DE-69400162-T2 (DE)
Inventor: BECKER DONALD W
IPC: H04L7/033
Filed: 1994-05-26
Granted: 1996-12-12
Abstract: A digital receiver (20) includes a tuner (24) and a demodulator (30) that obtains a baseband signal (36) carried in a received analog signal (22). A first sampler (46) operates at a preselected fixed asynchronous sampling rate on the baseband component to produce a first sampler output (48). A controllable digital filter (50) resamples the first sampler output to produce a filter output with a selectable resampling rate. The resampled output is time-position locked to baseband signal epochs. The resampling is processed to ascertain the bit stream of the baseband signal. The controllable filter sampling rate is automatically varied to correspond to the data rate of the baseband signal, so that the sampling rate of the first sampler need not change. Initial signal acquisition is achieved by operating the receiver as a frequency spectrum analyzer. A single signal-carrying band (66) is identified and demodulated, and a menu (72) carried on a transport layer (68) is read. This menu provides the center frequencies and bandwidths for all of the signals within an available frequency range, so that the receiver can be reconfigured for any desired signal. Changes in transmission characteristics of the signal can later be accommodated seamlessly by reading a change notice (74) transmitted in the transport layer and reconfiguring the receiver for the new transmission characteristics. <IMAGE>